[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …
Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis
N Van de Velde, MC Boily, M Drolet… - Journal of the …, 2012 - academic.oup.com
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …
[HTML][HTML] Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
D Mesher, K Soldan, R Howell-Jones, K Panwar… - Vaccine, 2013 - Elsevier
Background Reduction in the prevalence of vaccine type HPV infection in young women is
an early indication of the impact of the HPV immunisation programme and a necessary …
an early indication of the impact of the HPV immunisation programme and a necessary …
Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
S Abogunrin, GL Di Tanna, S Keeping, S Carroll… - BMC cancer, 2014 - Springer
Background Infection with human papillomavirus (HPV) is necessary for the development of
cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies …
cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies …
Modeling preventative strategies against human papillomavirus-related disease in developed countries
K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …
adolescent females has been introduced in most developed countries, supported by …
Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors
PJ Woestenberg, AJ King… - The Journal of …, 2018 - academic.oup.com
Background Observational postmarketing studies are important to assess vaccine
effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine …
effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine …
[HTML][HTML] HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
K Canfell, JJ Kim, S Kulasingam, J Berkhof… - Papillomavirus …, 2019 - Elsevier
Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …
of additional guidelines to those for general modelling. A specific framework is required to …
Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
Background Human papillomavirus (HPV) is the most widespread sexually transmitted
infection worldwide. It causes several health consequences, in particular accounting for the …
infection worldwide. It causes several health consequences, in particular accounting for the …
Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma
Importance Determining vaccine dose-level protection is essential to minimize program
costs and increase mass vaccination program feasibility. Currently, a 3-dose vaccination …
costs and increase mass vaccination program feasibility. Currently, a 3-dose vaccination …